RT Journal Article
SR Electronic
T1 Improving prediction of amyloid deposition in Mild Cognitive Impairment with a timed motor task
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.16.21259056
DO 10.1101/2021.06.16.21259056
A1 Schaefer, Sydney Y.
A1 Duff, Kevin
A1 Hooyman, Andrew
A1 Hoffman, John M.
YR 2021
UL http://medrxiv.org/content/early/2021/06/24/2021.06.16.21259056.abstract
AB Cortical amyloid deposition is one of the hallmark biomarkers of Alzheimer’s disease. However, given how cost- and time-intensive amyloid imaging can be, there is a continued need for a low-cost, non-invasive, and accessible enrichment strategy to pre-screen individuals for their likelihood of amyloid prior to imaging. Previous work supports the use of coordinated limb movement as a potential screening tool, even after controlling for cognitive and daily function. Thirty-six patients diagnosed with amnestic Mild Cognitive Impairment over the age of 65 underwent 18F-Flutemetamol amyloid-positron emission tomography imaging, then completed a timed motor task involving upper limb coordination. This task takes ∼5 minutes to administer and score. Multivariate linear regression and Receiver Operator Characteristic analyses showed that including motor task performance improved model prediction of amyloid burden. Results support the rationale for including functional upper extremity motor assessment as a cost- and time-effective means to screen participants for amyloid deposition.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02301546Funding StatementThis work was supported by the National Institutes of Health [grant numbers R01AG045163 and K01AG047926]. The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; in the preparation of the manuscript; or in the review or approval of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Utah IRBAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are not publicly available.